Strategizing The Scale-Up Of Cell Therapy Manufacturing Capacity

Mike Blankenstein, VP of patient supply operations AT Adaptimmune, discusses the company’s strategy for its cell therapy manufacturing facility...

Related Keywords

Mike Blankenstein ,Michelle Raley , ,